Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford researcher Dr Chunxiao Song has been awarded a CRUK-OHSU Project Award to work with Dr Thuy Ngo on liquid biopsy cancer diagnostic assays.

Cancer Research UK logoChunxiao Song, a group leader at the Ludwig Institute for Cancer Research, is developing a new highly sensitive technique to measure DNA methylation. This project award, jointly funded by CRUK and Oregon Health and Science University (OHSU) will allow him to collaborate with OHSU researcher Thuy Ngo. Thuy’s research focuses on the detection of RNA in the blood. Their aim is to use a combination of these epigenetic and transcriptome detection technologies to diagnose cancer earlier and provide information on where the cancer originated from. They will test their approach in the context of pancreatic and oesophageal cancer as these cancers have particularly low survival rates.

Read more about this story in the interview Chunxiao gave to CRUK here.

Update (February 2019): Chunxiao’s technology has been published in Nature Biotechnology. Read more about this here.

Similar stories

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including the work of OxCODE members.

Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – a recap

On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.